Search

• GSK to support training of frontline health workers across Ghana, Kenya and Nigeria

  Media

  GSK is to support the training of more than 9,000 health workers in Ghana, Kenya and Nigeria over the next three years.

  https://www.gsk.com/en-gb/media/press-releases/gsk-to-support-training-of-frontline-health-workers-across-ghana-kenya-and-nigeria/

  First published: 22 May 2015

• GSK increases stake in Indian Pharmaceuticals subsidiary to 75 per cent after Open Offer

  Media

  GSK announced that, it has successfully increased its stake in its publicly-listed pharmaceuticals subsidiary in India.

  https://www.gsk.com/en-gb/media/press-releases/gsk-increases-stake-in-indian-pharmaceuticals-subsidiary-to-75-per-cent-after-open-offer/

  First published: 10 March 2014

• Serious Fraud Office Investigation

  Media

  GSK has today been informed by UK's SFO that it has opened a formal criminal investigation into the Group’s commercial practices.

  https://www.gsk.com/en-gb/media/press-releases/serious-fraud-office-investigation/

  First published: 27 May 2014

• 

  Sir Jonathan Symonds CBE

  Company

  Jon was appointed to the Board as Chair on 1 September 2019 with extensive international financial, life sciences and governance experience.

  https://www.gsk.com/en-gb/company/board-of-directors-and-leadership-team/sir-jonathan-symonds/

  First published: 27 February 2025

• GSK announces regulatory submissions for mepolizumab in severe eosinophilic asthma

  Media

  GSK announced that it has filed regulatory submissions in the USA and Europe for mepolizumab for patients with severe eosinophilic asthma

  https://www.gsk.com/en-gb/media/press-releases/gsk-announces-regulatory-submissions-for-mepolizumab-in-severe-eosinophilic-asthma/

  First published: 05 November 2014

• Results announcement for fourth quarter 2013

  Media

  GSK announces core EPS of 112.2p and dividend of 78p.

  https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-fourth-quarter-2013/

  First published: 05 February 2014

• Regulatory update on divestment of Nimenrix and Mencevax

  Media

  GSK is divesting its meningitis vaccines Nimenrix and Mencevax to Pfizer Ireland Pharmaceuticals (a subsidiary of Pfizer Inc).

  https://www.gsk.com/en-gb/media/press-releases/regulatory-update-on-divestment-of-nimenrix-and-mencevax/

  First published: 22 June 2015

• 

  GSK announces Sir Dave Lewis appointed Non-Executive Chair Designate of independent Consumer Healthcare company

  Media

  GSK announces Sir Dave Lewis appointed Non-Executive Chair Designate of independent Consumer Healthcare company

  https://www.gsk.com/en-gb/media/press-releases/gsk-announces-sir-dave-lewis-appointed-non-executive-chair-designate-of-independent-consumer-healthcare-company/

  First published: 20 December 2021

• Update on three-part transaction with Novartis

  Media

  GSK today announces good progress on obtaining clearances and approvals to enable completion of its three-part transaction with Novartis

  https://www.gsk.com/en-gb/media/press-releases/update-on-three-part-transaction-with-novartis/

  First published: 25 February 2015

• Triumeq® (dolutegravir/abacavir/lamivudine) single-tablet regimen receives positive CHMP opinion in Europe for the treatment of HIV

  Media

  ViiV Healthcare today announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion.

  https://www.gsk.com/en-gb/media/press-releases/triumeq-dolutegravirabacavirlamivudine-single-tablet-regimen-receives-positive-chmp-opinion-in-europe-for-the-treatment-of-hiv/

  First published: 27 June 2014